Evidence map›Paper›PMID 26846266›Full record

ArticleTechnology in cancer research & treatment2017

MicroRNA-96 Regulates Apoptosis by Targeting PDCD4 in Human Glioma Cells.

Qing-Qing Ma, Jian-Ting Huang, Yun-Gang Xiong, Xiao-Yan Yang, Ran Han, Wang-Wen Zhu

Open access · bronzeAbstract read
In one paragraph

Article in Technology in cancer research & treatment, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Qing-Qing Ma1 Clinical Laboratory, Guizhou Aerospace Hospital, Zunyi, China.
Jian-Ting Huang2 Department of Anesthesiology, The People's Hospital of Chengyang District, Qingdao, China.
Yun-Gang Xiong1 Clinical Laboratory, Guizhou Aerospace Hospital, Zunyi, China.
Xiao-Yan Yang1 Clinical Laboratory, Guizhou Aerospace Hospital, Zunyi, China.
Ran Han1 Clinical Laboratory, Guizhou Aerospace Hospital, Zunyi, China.
Wang-Wen Zhu1 Clinical Laboratory, Guizhou Aerospace Hospital, Zunyi, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glioblastoma multiforme, the most common and aggressive form of primary brain tumor, presents a dismal prognosis. MicroRNAs play a critical role in the initiation, progression, and metastasis of cancer; however, the potential biological role of miRNAs in glioblastoma multiforme remains largely unknown. In our study, we found that microRNA-96 is upregulated in glioma tissues than in normal human brains. Transfection of microRNA-96 mimics into glioma cells significantly decreases apoptosis by suppressing PDCD4, a well-known tumor suppressor that is involved in apoptosis. In contrast, knockdown of microRNA-96 enhanced apoptosis. In vivo, microRNA-96 overexpression inhibits the apoptosis and increases tumor growth. These data suggest that microRNA-96 is a potential molecular target for glioma treatment.

Indexed as

Gene Expression Regulation, NeoplasticRNA InterferenceAnimalsApoptosisApoptosis Regulatory ProteinsCell Line, TumorDisease Models, AnimalGene ExpressionGenes, Tumor SuppressorGliomaHumansMiceMicroRNAsRNA-Binding ProteinsXenograft Model Antitumor AssaysApoptosis Regulatory ProteinsMicroRNAsMIRN96 microRNA, humanPDCD4 protein, humanRNA-Binding ProteinsapoptosisgliomamicroRNA-96PDCD4

Identifiers

PMID26846266
PMCPMC5616120
OpenAlexW2281911306

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.